Core Insights - MariMed Inc. has entered into a licensing agreement with The Stoned Moose, a cannabis operator in Maine, to expand the distribution of its Betty's Eddies™ full-spectrum fruit chews in the state's $455 million cannabis market [1][2][3] - The new agreement allows for the distribution of Betty's Eddies to both adult-use and medical cannabis consumers, tapping into a market where medical cannabis sales accounted for over 50% of Maine's cannabis revenues in 2024 [2][3] - The CEO of MariMed expressed optimism about the brand's potential in Maine, citing its market leadership in Massachusetts, Maryland, and Delaware, and positioning this move as part of the company's "Expand the Brand" strategy [3] Company Overview - MariMed Inc. is recognized as a leading multi-state cannabis operator, specializing in the development and management of cultivation, production, and retail facilities [4] - The company boasts a portfolio of award-winning cannabis brands, including Betty's Eddies™, Bubby's Baked™, Vibations™, InHouse™, and Nature's Heritage™, which are well-regarded by consumers across the country [4]

Core Viewpoint - Digicann Ventures Ltd. has announced the postponement of its proposed reverse take-over (RTO) by 3Win Corp. to the second half of 2025 due to market volatility and depressed valuations in the cannabis sector [1][2]. Group 1: Proposed Transaction Details - The decision to delay the RTO aims to refine strategic objectives, enhance operational readiness, and explore additional opportunities to increase shareholder value [2]. - The completion of the Proposed Transaction requires shareholder approval, with at least two-thirds (66 2/3%) of votes needed or a simple majority excluding interested parties [3]. - The transaction is subject to conditions, including a minimum cash requirement at closing and necessary regulatory approvals [4]. Group 2: Company Background - 3Win Corp. is a global distributor of CCELL® vape products and offers customization services for brands in the cannabis and hemp markets [9]. - 3Win's subsidiary, 3Win Holdings (Canada) Corp., focuses on the development and distribution of controlled substances under Canadian licenses, including cannabinoid products and psychedelic mushrooms [10]. Group 3: Regulatory and Compliance Information - None of the shares to be issued in connection with the Proposed Transaction will be registered under the U.S. Securities Act, limiting their sale within the United States [5]. - The Proposed Transaction and the listing of the resulting issuer are subject to review by the Exchange, and conditional approval has not yet been granted [8].